nivolumabnivolumab SCrHuPH20
… of nivolumab SC 720 mg or 960 mg±rHuPH20 2000 U/mL followed by nivolumab intravenous (IV) 480 mg every 4 weeks (Q4W). Patients receiving…
2articles mentioning drugs
9drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: rHuPH20 ×
rHuPH20
This drug is selected. Its supporting articles are shown below.
Articles mentioning rHuPH20
2 articles · page 1 of 1efgartigimodrecombinant human hyaluronidase PH20rHuPH20PH20 SCHealth Assessment QuestionnaireSystemic SclerosisSystemic sclerosis (SSc)NCT06655155interstitial lung disease
…SSc will be randomized 2:1 to receive weekly administrations of efgartigimod or placebo PH20 SC (coformulated with recombinant human hyaluro…